2012
DOI: 10.1016/j.gene.2011.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
1
4

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 37 publications
1
30
1
4
Order By: Relevance
“…This strong association has been confirmed also in Armenia and Israel. [20] These results should raise the necessity to carefully consider the early treatment of asymptomatic or mildly symptomatic patients with homozygous M694V, especially in countries where amyloidosis is rare like Egypt, moreover treatment in such cases should not be given on an on demand basis.…”
Section: Discussionmentioning
confidence: 99%
“…This strong association has been confirmed also in Armenia and Israel. [20] These results should raise the necessity to carefully consider the early treatment of asymptomatic or mildly symptomatic patients with homozygous M694V, especially in countries where amyloidosis is rare like Egypt, moreover treatment in such cases should not be given on an on demand basis.…”
Section: Discussionmentioning
confidence: 99%
“…Familial Mediterranean fever is one of the leading causes of secondary amyloidosis, which is still the more common type of systemic amyloidosis in developing countries 19 . Synovitis and inflammation due to amyloid deposition may result first in enthesophyte formation and then in erosion 8 .…”
Section: Discussionmentioning
confidence: 99%
“…In 2012, Akpolat et al did a comprehensive literature review and concluded that M694V was associated with amyloidosis in the Turkish population as well [32]. A final statement has come from the Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) initiative.…”
Section: Debate: Disease Causing Mutations Are Loss-of-function Mutatmentioning
confidence: 99%